cupure logo
trumptrumpsepsteindealukrainebritishhousetariffspolicedata

Cheaper generic Ozempic is coming to Canada after Novo Nordisk fails to maintain patent in this country

Cheaper generic Ozempic is coming to Canada after Novo Nordisk fails to maintain patent in this country
Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper generic copycats

Comments

World news